The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Targeting resistant prostate cancer with ATR and PARP inhibition (TRAP trial): A phase II study.
 
Zachery R. Reichert
Consulting or Advisory Role - Dendreon
Research Funding - AstraZeneca (Inst)
 
Stephanie Daignault
Consulting or Advisory Role - Boston Scientific
 
Benjamin A. Teply
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Inovio Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - Patents related to drug delivery technology with royalties paid via MIT
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen
 
Michael Edward Devitt
Consulting or Advisory Role - Bayer
 
Elisabeth I. Heath
Honoraria - Bayer; Dendreon; Sanofi; Seagen
Consulting or Advisory Role - Agensys
Speakers' Bureau - Sanofi
Research Funding - Agensys (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Caris Life Sciences (Inst); Celgene (Inst); Celldex (Inst); Corcept Therapeutics (Inst); Curemeta (Inst); Dendreon (Inst); eFFECTOR Therapeutics (Inst); Esanik (Inst); Fortis (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Ignyta (Inst); Inovio Pharmaceuticals (Inst); Medivation (Inst); Merck (Inst); Merck Sharp & Dohme (Inst); Millennium (Inst); Oncolys BioPharma (Inst); Plexxikon (Inst); Seagen (Inst); Synta (Inst); Tokai Pharmaceuticals (Inst); Zenith Epigenetics (Inst); Zenith Epigenetics (Inst)
Other Relationship - Caris Centers of Excellence